本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

4.09
-0.2750-6.31%
成交量:223.72万
成交额:942.23万
市值:21.85亿
市盈率:-4.00
高:4.37
开:4.31
低:4.08
收:4.36
52周最高:7.18
52周最低:2.77
股本:5.35亿
流通股本:5.22亿
量比:3.55
换手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
净资产收益率:-56.58%
总资产收益率:-27.33%
市净率:2.39
市盈率(LYR):-2.83

数据加载中...

2026/10/06

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS 董事 Borgeson Blake 拟减持50000股,总价约24.2万美元
2026/10/06

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals董事Robert Hershberg拟减持25000股,总价约12.5万美元
2026/09/21

重要事件披露

Form 8-K - Current report
2026/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors